How did you first get involved in researching 103-26-4

Welcome to talk about 103-26-4, If you have any questions, you can contact Ponirakis, G; Elhadd, T; Chinnaiyan, S; Dabbous, Z; Siddiqui, M; Al-muhannadi, H; Petropoulos, I; Khan, A; Ashawesh, KAE; Dukhan, KMO; Mahfoud, ZR; Murgatroyd, C; Slevin, M; Malik, RA or send Email.. Recommanded Product: Methyl 3-phenyl-2-propenoate

I found the field of Endocrinology & Metabolism very interesting. Saw the article Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar published in 2019.0. Recommanded Product: Methyl 3-phenyl-2-propenoate, Reprint Addresses Malik, RA (corresponding author), Qatar Fdn, Educ City, Weill Cornell Med Qatar, Doha, Qatar.; Malik, RA (corresponding author), Manchester Metropolitan Univ, Fac Sci & Engn, Manchester, Lancs, England.; Malik, RA (corresponding author), Hamad Med Corp, Natl Diabet & Endocrine Ctr, Hamad Gen Hosp, Doha, Qatar.; Malik, RA (corresponding author), Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England.. The CAS is 103-26-4. Through research, I have a further understanding and discovery of Methyl 3-phenyl-2-propenoate

Aims/Introduction Painful diabetic peripheral neuropathy (PDPN) has a significant impact on the patient’s quality of life. The prevalence of PDPN in the Middle East and North Africa region has been reported to be almost double that of populations in the UK. We sought to determine the prevalence of PDPN and its associated factors in type 2 diabetes mellitus patients attending secondary care in Qatar. Materials and Methods This was a cross-sectional study of 1,095 participants with type 2 diabetes mellitus attending Qatar’s two national diabetes centers. PDPN and impaired vibration perception on the pulp of the large toes were assessed using the Douleur Neuropathique en 4 questionnaire with a cut-off >= 4 and the neurothesiometer with a cut-off >= 15 V, respectively. Results The prevalence of PDPN was 34.5% (95% confidence interval [CI] 31.7-37.3), but 80% of these patients had not previously been diagnosed or treated for this condition. Arabs had a higher prevalence of PDPN compared with South Asians (P < 0.05). PDPN was associated with impaired vibration perception adjusted odds ratio (AOR) 4.42 (95% CI 2.92-6.70), smoking AOR 2.43 (95% CI 1.43-4.15), obesity AOR 1.74 (95% CI 1.13-2.66), being female AOR 1.65 (95% CI: 1.03-2.64) and duration of diabetes AOR 1.08 (95% CI 1.05-1.11). Age, poor glycemic control, hypertension, physical activity and proteinuria showed no association with PDPN. Conclusions PDPN occurs in one-third of type 2 diabetes mellitus patients attending secondary care in Qatar, but the majority have not been diagnosed. Arabs are at higher risk for PDPN. Impaired vibration perception, obesity and smoking are associated with PDPN in Qatar. Welcome to talk about 103-26-4, If you have any questions, you can contact Ponirakis, G; Elhadd, T; Chinnaiyan, S; Dabbous, Z; Siddiqui, M; Al-muhannadi, H; Petropoulos, I; Khan, A; Ashawesh, KAE; Dukhan, KMO; Mahfoud, ZR; Murgatroyd, C; Slevin, M; Malik, RA or send Email.. Recommanded Product: Methyl 3-phenyl-2-propenoate

Reference:
Article; Weng, Shiue-Shien; Ke, Chih-Shueh; Chen, Fong-Kuang; Lyu, You-Fu; Lin, Guan-Ying; Tetrahedron; vol. 67; 9; (2011); p. 1640 – 1648;,
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics